Accidental injection of a U.S. Air Force aviator by a pralidoxime chloride auto-injector: a case report.
To counter the threat of organophosphate nerve agents, military personnel may be issued auto-injectors containing pralidoxime chloride. This drug helps to dephosphorylate the nerve agent-acetylcholinesterase complex and, thus, regenerate the enzyme. In non-poisoned persons, pralidoxime chloride is rapidly excreted by the kidneys and is fairly well tolerated. We present the first reported case of an accidental injection of an Air Force aviator by an auto-injector. The patient recovered well with no specific treatment needed. The pharmacology and toxicology of pralidoxime chloride are discussed.
Yamane
G K
GK
USAF School of Aerospace Medicine, Brooks AFB, TX 78235-5252, USA.
D000062:Accidents, Occupational; D000328:Adult; D000337:Aerospace Medicine; D000931:Antidotes / Q000378:metabolism / Q000506:poisoning*; D002619:Chemical Warfare Agents; D002801:Cholinesterase Reactivators / Q000378:metabolism / Q000506:poisoning*; D006801:Humans; D007273:Injections, Intramuscular / Q000009:adverse effects* / Q000295:instrumentation; D008297:Male; D008657:Metabolic Clearance Rate; D008889:Military Personnel; D011220:Pralidoxime Compounds / Q000378:metabolism / Q000506:poisoning*; D012646:Self Administration / Q000009:adverse effects* / Q000295:instrumentation; D014481:United States
D000931:Antidotes; D002619:Chemical Warfare Agents; D002801:Cholinesterase Reactivators; D011220:Pralidoxime Compounds; C028797:pralidoxime